MIRIAM DE LEON: Open Payments
NPI 1396206983 · HARLINGEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$621 in 32 payments from 4 companies in 2025. Trend: 2023 $515 · 2024 $746 · 2025 $621
Food & beverage: $621
| Company | Payments | Amount |
|---|---|---|
| Ipsen Biopharmaceuticals, Inc | 10 | $276 |
| ABBVIE INC. | 16 | $160 |
| Janssen Biotech, Inc. | 3 | $137 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $47 |
Products named: IQIRVO, TREMFYA, LINZESS, XIFAXAN, RINVOQ, CREON, MAVYRET, SKYRIZI.
Industry payments across TX — which companies pay providers there.
